Immune Targeting Systems develops synthetic vaccines for mutating viruses, improving the quality of life for those infected by viruses.
8 years ago
HealthCap, Novartis Venture Fund, Truffle Capital, London Technology Fund
Use Immune Targeting Systems's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Immune Targeting Systems's mobile downloads and app ranks to evaluate the performance of their mobile apps.